Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02389829Phase 4Completed
Phase 4, randomised trial of hydromorphone in migraine (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Number of Participants With Sustained Headache Relief Assessed by Self-evaluation at 48 hours. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02389829.